Talatisamine


CAS No. : 20501-56-8

20501-56-8
Price and Availability of CAS No. : 20501-56-8
Size Price Stock
5mg $65 In-stock
10mg $110 In-stock
50 mg Get quote
100 mg Get quote
We match the lowest price on market.

We offer a substantial discount on larger orders, please inquire via [email protected]

or Fax: (86)21-58955996

Inquiry for price and availability only. Please place your order via our email or fax.

Cat. No. : HY-N0663
M.Wt: 421.57
Formula: C24H39NO5
Purity: >98 %
Solubility: DMSO : 50 mg/mL (ultrasonic)
Introduction of 20501-56-8 :

Talatisamine is an orally active cyclophilin D activator isolated from the roots of Aconitum carmichaeli Debx. Talatisamine exerts biological functions by activating cyclophilin D, inhibiting Ca2+-dependent opening of the mitochondrial permeability transition pore (mPTP) (IC50=78 μM), and blocking delayed rectifier K+ channels (IC50=146 μM). Talatisamine possesses both antioxidant and membrane-stabilizing properties, effectively inhibits lipid peroxidation and protects mitochondrial membrane function. Talatisamine exhibits multiple activities including antiarrhythmic, hypotensive, anti-inflammatory, anticancer and neuroprotective effects. Talatisamine finds applications in the research of ischemic diseases, rheumatoid arthritis, inflammation-related diseases and Alzheimer's disease[1][2][3].
In Vitro:Talatisamine (10-200 μM) inhibits Ca2+-dependent mPTP opening in isolated rat liver mitochondria in a concentration-dependent manner, with an IC50 of 78 μM[1].
Talatisamine (10-200 μM) inhibits Ca2+-dependent mPTP opening in isolated rat heart mitochondria in a concentration-dependent manner in vitro, and its activity is weaker than that in rat liver mitochondria[1].
Talatisamine (10-200 μM) exhibits enhanced concentration-dependent inhibition of Ca2+-dependent mPTP opening in isolated rat liver mitochondria in the presence of cyclosporin A (CsA)[1].
Talatisamine (50-200 μM) inhibits Fe2+/ascorbic acid-induced MDA production in isolated rat liver mitochondria in vitro in a concentration-dependent manner[1].
Talatisamine (10-100 μM) inhibits Fe2+/ascorbic acid-induced lipid peroxidation (LPO) in isolated rat liver mitochondria in a concentration-dependent manner in vitro, with the maximum inhibitory effect observed at 100 μM[1].
Talatisamine exhibits no inhibitory effect on voltage-gated Na+ or Ca2+ currents at concentrations up to 3 mM[2]. In Vivo:Talatisamine (1 mg/kg; i.v.; single dose; 2-8 mg/kg; p.o.; single dose) exhibits rapid elimination in male ICR mice following intravenous or oral administration, with absolute oral bioavailability ranging from 65.0% to 79.2% across tested doses[2].

Your information is safe with us.